ScreenerHero

CDXS Codexis, Inc.

NAS · US · Healthcare · Biotechnology · codexis.com
1.410USD+3.68%Mkt Cap: 154.40M $P/E: —

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap154.40M USD
Enterprise Value166.60M USD
Revenue (TTM)77.68M USD
Gross Profit61.05M USD
Net Income (TTM)-43.97M USD
Revenue/Share0.86 USD
Last Price1.410 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees146
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.25
PEG13.53
EV/EBITDA-8.75
EV/Revenue2.14
P/S1.92
P/B3.77
EPS (TTM)-0.33
EPS (Forward)-0.32
52W Range
0.960022% of range2.980
52W High2.980 USD
52W Low0.9600 USD
Profitability
Gross Margin86.73%
Oper. Margin-75.29%
EBITDA Margin-24.52%
Profit Margin-62.47%
ROE-87.03%
ROA-29.75%
Growth
Revenue Growth-2.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.38M USD
CapEx (TTM)4.47M USD
FCF Margin2.74%
FCF Yield1.38%
Net Debt17.67M USD
Net Debt/EBITDA-0.93
Balance Sheet
Debt/Equity1.45
Current Ratio3.06
Quick Ratio2.83
Book Value/Sh0.36 USD
Cash/Share0.50 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.143 USD
Upside (mean)+335.7%
Target Range2.000 USD – 11.00 USD
2.000+335.7% to mean11.00
# Analysts7
Ownership
Shares Out.109.51M
Float82.35M
Insiders7.12%
Institutions70.15%
Short Interest
Short Ratio4.4d
Short % Float3.72%
Short % Out.3.68%
Shares Short4.03M
Short (prev mo.)3.72M
Technical
SMA 501.474 (-4.3%)
SMA 2001.850 (-23.8%)
Beta2.55
S&P 52W Chg16.45%
Avg Vol (30d)887.84K
Avg Vol (10d)696.58K
Technical Indicators
RSI (14)46.5
MACD-0.0525
MACD Signal-0.0689
MACD Hist.+0.0164
BB Upper1.473 USD
BB Middle1.388 USD
BB Lower1.304 USD
BB Width12.16%
ATR (14)0.0829 USD
Vol Ratio (20d)1.22x